Lv562
1404 积分 2024-10-27 加入
Aldosterone as a Mediator of Cardiovascular Damage
4天前
已完结
Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease
21天前
已完结
Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma
26天前
已完结
IL-17 as a therapeutic target in cardiovascular diseases: Mechanistic insights and translational opportunities
26天前
已完结
Interleukin 23 receptor: Expression and regulation in immune cells
29天前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Esaxerenone, a Novel Mineralocorticoid Receptor Antagonist: A Review
1个月前
已完结
Endothelin ETA receptor antagonism in cardiovascular disease
1个月前
已完结
The Th17/Treg imbalance in patients with primary hyperaldosteronism and resistant hypertension
1个月前
已完结
The Th17/Treg imbalance in patients with primary hyperaldosteronism and resistant hypertension
1个月前
已关闭
Exploring the pathogenesis linking primary aldosteronism and obstructive sleep apnea via bioinformatic analysis
1个月前
已关闭
皖公网安备34019202002308
